1. Home
  2. MAA vs RLAY Comparison

MAA vs RLAY Comparison

Compare MAA & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid-America Apartment Communities Inc.

MAA

Mid-America Apartment Communities Inc.

HOLD

Current Price

$139.20

Market Cap

15.3B

Sector

Real Estate

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.32

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAA
RLAY
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.3B
1.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MAA
RLAY
Price
$139.20
$8.32
Analyst Decision
Buy
Strong Buy
Analyst Count
20
7
Target Price
$155.25
$16.00
AVG Volume (30 Days)
976.9K
2.2M
Earning Date
02-04-2026
11-06-2025
Dividend Yield
4.40%
N/A
EPS Growth
6.34
N/A
EPS
4.71
N/A
Revenue
$2,203,402,000.00
$8,355,000.00
Revenue This Year
$1.82
$20.47
Revenue Next Year
$2.02
N/A
P/E Ratio
$29.52
N/A
Revenue Growth
0.92
N/A
52 Week Low
$125.75
$1.78
52 Week High
$173.38
$9.04

Technical Indicators

Market Signals
Indicator
MAA
RLAY
Relative Strength Index (RSI) 65.11 57.67
Support Level $133.10 $8.13
Resistance Level $137.61 $8.76
Average True Range (ATR) 2.08 0.48
MACD 0.54 -0.01
Stochastic Oscillator 97.74 54.63

Price Performance

Historical Comparison
MAA
RLAY

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: